MALDI MSI Separation of Same Donor's Fingermarks Based on Time of Deposition-A Proof-of-Concept Study

被引:5
|
作者
Frisch, Kim [1 ]
Nielsen, Kristine Lykke [1 ]
Francese, Simona [2 ]
机构
[1] Aarhus Univ, Dept Forens Med, DK-8200 Aarhus N, Denmark
[2] Sheffield Hallam Univ, Coll Hlth Wellbeing & Life Sci, Ctr Mass Spectrometry Imaging, Biomol Sci Res Ctr, Sheffield S1 1WB, England
来源
MOLECULES | 2023年 / 28卷 / 06期
关键词
MALDI MSI; overlapping; fingermarks; age; IDENTIFICATION; METHODOLOGY;
D O I
10.3390/molecules28062763
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Despite the advent of DNA profiling, fingerprints still play an important role in suspect identification. However, if single crime scene marks may be challenging to identify, overlapping fingermarks, understandably, pose an even greater challenge. In the last decade, mass spectrometry-imaging methods have provided a possible solution to the separation of fingermarks from two or more donors, based on the differential chemical composition. However, there are no studies attempting to separate overlapping marks from the same donor. This is important in relation to fingermark deposition at different times, which could be critical, for example, to ascertain legitimate access to the scene. In the work presented here, we investigate whether Matrix-Assisted Laser Desorption Ionisation Mass Spectrometry Imaging can separate the same donor's fingermarks deposited at different times based on intra-donor fingermark composition variability. Additionally, the hypothesis that the different times of deposition could be also determined was investigated in the view of linking the suspect at the scene at different times; the dating window of MALDI MSI within the selected molecular range was explored. Results show that it is possible to separate overlapping fingermarks from the same donor in most cases, even from natural marks. Fresh marks (0 days) could be separated from those of fourteen days of age, though the latter could not be distinguished from the set aged for seven days. Due to the use of only one donor, these are to be considered preliminary data, though findings are interesting enough to warrant further investigation of the capabilities and limitations of this approach using a larger cohort of donors.
引用
收藏
页数:13
相关论文
共 26 条
  • [21] Deep learning-based synthetization of real-time in-treatment 4D images using surface motion and pretreatment images: A proof-of-concept study
    Huang, Yuliang
    Dong, Zhengkun
    Wu, Hao
    Li, Chenguang
    Liu, Hongjia
    Zhang, Yibao
    MEDICAL PHYSICS, 2022, 49 (11) : 7016 - 7024
  • [22] Performing Dynamic Weight-Shifting Balance Exercises With a Smartphone-Based Wearable Telerehabilitation System for Home Use by Individuals With Parkinson's Disease: A Proof-of-Concept Study
    Lee, Beom-Chan
    An, Junmo
    Kim, Jiyeon
    Lai, Eugene C. C.
    IEEE TRANSACTIONS ON NEURAL SYSTEMS AND REHABILITATION ENGINEERING, 2023, 31 : 456 - 463
  • [23] Time-Varying Associations Between Device-Based and Ecological Momentary Assessment-Reported Sedentary Behaviors and the Concurrent Affective States Among Adolescents: Proof-of-Concept Study
    Zink, Jennifer
    Yang, Chih-Hsiang
    Alves, Jasmin M.
    McAlister, Kelsey L.
    Huh, Jimi
    Pentz, Mary Ann
    Page, Kathleen A.
    Dunton, Genevieve F.
    Belcher, Britni R.
    JMIR FORMATIVE RESEARCH, 2022, 6 (06)
  • [24] Real-time automatic image-based slice tracking of gadolinium-filled balloon wedge catheter during MR-guided cardiac catheterization: A proof-of-concept study
    Vidya Shankar, Rohini
    Huang, Li
    Neji, Radhouene
    Kowalik, Grzegorz
    Neofytou, Alexander Paul
    Mooiweer, Ronald
    Moon, Tracy
    Mellor, Nina
    Razavi, Reza
    Pushparajah, Kuberan
    Roujol, Sebastien
    MAGNETIC RESONANCE IN MEDICINE, 2024, 91 (01) : 388 - 397
  • [25] Aroylhydrazones constitute a promising class of 'metal-protein attenuating compounds' for the treatment of Alzheimer's disease: a proof-of-concept based on the study of the interactions between zinc(II) and pyridine-2-carboxaldehyde isonicotinoyl hydrazone
    Cukierman, Daphne S.
    Accardo, Elio
    Gomes, Rosana Garrido
    De Falco, Anna
    Miotto, Marco C.
    Ramalho Freitas, Maria Clara
    Lanznaster, Mauricio
    Fernandez, Claudio O.
    Rey, Nicolas A.
    JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY, 2018, 23 (08): : 1227 - 1241
  • [26] Aroylhydrazones constitute a promising class of ‘metal-protein attenuating compounds’ for the treatment of Alzheimer’s disease: a proof-of-concept based on the study of the interactions between zinc(II) and pyridine-2-carboxaldehyde isonicotinoyl hydrazone
    Daphne S. Cukierman
    Elio Accardo
    Rosana Garrido Gomes
    Anna De Falco
    Marco C. Miotto
    Maria Clara Ramalho Freitas
    Mauricio Lanznaster
    Claudio O. Fernández
    Nicolás A. Rey
    JBIC Journal of Biological Inorganic Chemistry, 2018, 23 : 1227 - 1241